BillionToOne drops after in-line quarter, maintains annual revenue outlook

BillionToOne

06/08/2026 18:07

Updates
** Shares of molecular diagnostics co BillionToOne BLLN.O fall 38.50% to $92.23
** Co maintained annual revenue forecast to be between $450.0 million and $465.0 million
** Q2 rev of $109.4 million were about in line with estimates
** BLLN came in hot into the Q2 print and surprised folks with an in-line quarter, says brokerage BTIG
** At least two brokerages cut PT on co
** Stock up 12.6% YTD

(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))